FDA Reforms Fuel the Biotech Industry Growth


November 30, 2011
5 Pages - SKU: GBDT6713320
License type:
FDA Reforms Fuel the Biotech Industry Growth

Summary

GlobalData, the industry analysis specialist, has released its new report, “FDA Reforms Fuel the Biotech Industry Growth”. The report is an essential source of information and analysis on the current scenario of biotechnology industry.The report provides insights on the hurdles faced by the biotech industry in the past. Most importantly, the report provides valuable insights on the FDA reforms that are helping the biotech industry gain a foothold again. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the current scenario of the biotechnology industry. Its scope includes -
  • Hurdles faced by the biotech industry.
  • FDA reforms helping the biotech industry growth.
  • Patent cliff challenging the pharma industry
  • Steps being taken by the pharma companies
Reasons to buy

The report will enhance your decision making capability. It will allow you to -
  • Develop business strategies by understanding the current scenario of biotech industry
  • Formulate effective strategies to cope with the patent cliff
  • Organize your sales and marketing efforts by identifying the current trends in the pharmaceutical market



More Research & Development reports by GlobalData

PharmaLeaders: Innovative Mid-Cap Biotechnology Benchmark Report - Financial Benchmarking, Pipeline Assessment & Competitive Analysis of Innovative Biotechs by GlobalData
PharmaLeaders: Innovative Mid-Cap Biotechnology Benchmark Report - Financial Benchmarking, Pipeline Assessment & Competitive Analysis of Innovative BiotechsSummaryThe Innovative Mid-Cap Biotech Benchmark Report applies GlobalData’s proprietary ...
Biotech Strategy 2012 - Licensing, Collaboration, and M&A Trends by GlobalData
Biotech Strategy 2012 - Licensing, Collaboration, and M&A TrendsSummary GlobalData’s Biotech Strategy 2012 - Licensing, Collaboration, and M&A Trends report analyzes 20 strategic deals ...
Global Healthcare Policy Analysis 2012 – Regulatory, Pricing, and Reimbursement Assessment by GlobalData
Global Healthcare Policy Analysis 2012 – Regulatory, Pricing, and Reimbursement AssessmentSummaryGlobalData’s Global Healthcare Policy Analysis 2012 – Regulatory, Pricing, and Reimbursement Assessment provides an in-depth ...
Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders by GlobalData
Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell DisordersSummaryGlobalData’s report, “Breaking the Gene Therapy Barrier for Life-Threatening Red Blood Cell Disorders” takes a ...
See all reports like this >>